Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Wolfgang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The European Respiratory Journal|August 11, 2012
Defining race/ethnicity and explaining difference in research studies on lung functionLundy Braun, Melanie Wolfgang, Kay Dickersin
American Journal of Public Health|June 6, 2014
Eliminating tuberculosis one neighborhood at a timeJ Peter Cegielski, David E Griffith, Paul K McGaha, et al.
American Journal of Public Health|October 20, 2012
Eliminating tuberculosis one neighborhood at a timeJ Peter Cegielski, David E Griffith, Paul K McGaha, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|December 5, 2013
[Eliminating tuberculosis one neighborhood at a time]J Peter Cegielski, David E Griffith, Paul K McGaha, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studiesEkaterina V Kurbatova, J Peter Cegielski, Christian Lienhardt, et al.
Lancet (London, England)|September 4, 2012
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyTracy Dalton, Peter Cegielski, Somsak Akksilp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceJ Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The European Respiratory Journal|August 11, 2012
Defining race/ethnicity and explaining difference in research studies on lung functionLundy Braun, Melanie Wolfgang, Kay Dickersin
American Journal of Public Health|June 6, 2014
Eliminating tuberculosis one neighborhood at a timeJ Peter Cegielski, David E Griffith, Paul K McGaha, et al.
American Journal of Public Health|October 20, 2012
Eliminating tuberculosis one neighborhood at a timeJ Peter Cegielski, David E Griffith, Paul K McGaha, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|December 5, 2013
[Eliminating tuberculosis one neighborhood at a time]J Peter Cegielski, David E Griffith, Paul K McGaha, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studiesEkaterina V Kurbatova, J Peter Cegielski, Christian Lienhardt, et al.
Lancet (London, England)|September 4, 2012
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyTracy Dalton, Peter Cegielski, Somsak Akksilp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceJ Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, et al.
Pageof 1